Patent details

Basic Information

Publication number:

EP3071235

PCT Application Number:

US2016013305

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167040856

PCT Publication Number:

WO2016122889

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF

French Title of Invention:

COMPOSITIONS THÉRAPEUTIQUES DE GYLCANE ET PROCÉDÉS ASSOCIÉS

German Title of Invention:

GLYCANTHERAPEUTIKA UND ENTSPRECHENDE VERFAHREN

SPC Number:

Dates

Filing date:

13/01/2016

Grant date:

13/12/2017

EP Publication Date:

28/09/2016

PCT Publication Date:

04/08/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2017

EP B1 Publication Date:

13/12/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/01/2023

Expiration date:

13/01/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/12/2017

 

 

Name:

Kaleido Biosciences, Inc.

Address:

18 Crosby Street, Bedford, MA 01730, United States (US)

Agent

Name:

VALIPAT

From:

19/01/2018

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

GEREMIA, John M.

Address:

United States (US)

2

Name:

YAMANAKA, Yvonne J.

Address:

United States (US)

3

Name:

MILWID, Jack

Address:

United States (US)

4

Name:

SILVERMAN, Jared

Address:

United States (US)

5

Name:

VON MALTZAHN, Geoffrey A.

Address:

United States (US)

Priority

1

Priority Number:

201562108039 P

Priority Date:

26/01/2015

Priority Country:

United States (US)

2

Priority Number:

201562152016 P

Priority Date:

23/04/2015

Priority Country:

United States (US)

3

Priority Number:

201562152017 P

Priority Date:

23/04/2015

Priority Country:

United States (US)

4

Priority Number:

201562152007 P

Priority Date:

23/04/2015

Priority Country:

United States (US)

5

Priority Number:

201562152011 P

Priority Date:

23/04/2015

Priority Country:

United States (US)

6

Priority Number:

201562152005 P

Priority Date:

23/04/2015

Priority Country:

United States (US)

7

Priority Number:

201562217002 P

Priority Date:

10/09/2015

Priority Country:

United States (US)

8

Priority Number:

201562216995 P

Priority Date:

10/09/2015

Priority Country:

United States (US)

9

Priority Number:

201562216993 P

Priority Date:

10/09/2015

Priority Country:

United States (US)

10

Priority Number:

201562216997 P

Priority Date:

10/09/2015

Priority Country:

United States (US)

11

Priority Number:

201562238112 P

Priority Date:

06/10/2015

Priority Country:

United States (US)

12

Priority Number:

201562238110 P

Priority Date:

06/10/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7016; A61K 31/702; A61K 31/716; A61K 31/733; A61K 45/06; A61P 1/00;

Publication

European Patent Bulletin

1

Issue number:

201750

Publication date:

13/12/2017

Description:

Grant (B1)

2

Issue number:

201803

Publication date:

17/01/2018

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Power of attorney

Change Kind/ Decision Type:

Assignment

Deed Number:

RC20180000019A

Date Registered:

19/01/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

VALIPAT

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/01/2022

Last Annual Fee Paid Number:

7

Last Annual Fee Paid Amount:

82 Euro

Payer:

PAVIS GMBH

Filing date	Document type	Number of pages
19/01/2018	Request For Change	2